OCT 30, 2026 · REVIEW
Recent Advances in Synovial Sarcoma: Molecular Insights and Evolving Pharmacological Therapies
Cancer Investigation
Synovial sarcoma (SS) is a soft-tissue carcinoma primarily affecting teenagers and young adults caused by three oncoprotein fusions: SS18-SSX1, SS18-SSX2, or SS18-SSX4. The tumors